Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

VYNE VYNE Therapeutics Inc

2,45

-0,02 (-0,81%)

Zuletzt aktualisiert: 21:24:20

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

VYNE Therapeutics (NASDAQ:VYNE)
Historical Stock Chart
Von Jan 2025 bis Feb 2025

Click Here for more VYNE Therapeutics Charts.

VYNE Therapeutics (NASDAQ:VYNE)
Historical Stock Chart
Von Feb 2024 bis Feb 2025

Click Here for more VYNE Therapeutics Charts.

News VYNE Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 23 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 23 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 23 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 23 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 2 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 2 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 2 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 2 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 23 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Donnerstag 19 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 13 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere VYNE Therapeutics Inc News-Artikel

BNP PARIBAS ISSUANCE

Poste Italiane S.p.a

Lyxor Core UK Government...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen